5.1 Pharmacist Administration of Vaccines & Immunizations

Pharmacist Administration of Vaccines & Immunizations

Under New Jersey law, the clinical scope of pharmacy practice includes the administration of vaccines and immunizations to eligible patients. Governed primarily by N.J.A.C. 13:39-4.21 and N.J.A.C. 13:39-4.22, New Jersey permits certified pharmacists—as well as registered pharmacy interns and pharmacy externs acting under direct pharmacist supervision—to administer injectable, oral, and intranasal immunizations. To exercise this clinical authority, practitioners must satisfy stringent educational prerequisites, adhere to strict age thresholds, maintain life-saving emergency countermeasures, and fulfill state registry reporting mandates.

Candidates preparing for the Multistate Pharmacy Jurisprudence Examination (NJ MPJE) must master the legal distinctions between prescription-directed and standing-order immunization, the precise age cutoffs for pediatric vaccine administration, emergency response standards, and the required timelines for inter-professional communication.

---

Pharmacist Qualification & Certification Prerequisites

Before a New Jersey-licensed pharmacist can administer any vaccine, the licensee must satisfy three fundamental statutory criteria codified in N.J.A.C. 13:39-4.21(a):

                               Immunization Credentials
                                          │
         ┌────────────────────────────────┼────────────────────────────────┐
         ▼                                ▼                                ▼
  20-Hour Certificate            Current Healthcare BLS           Biennial Maintenance
 • ACPE-accredited course       • In-person hands-on skills     • Min 2 hours immunization CE
 • Hands-on injection skills    • Adult, child, infant CPR      • Part of 30 total CE credits
 • Immunology & adverse events  • Automated External Defibrillator

1. Education & Training Program

The pharmacist must successfully complete an immunization training program accredited by the Accreditation Council for Pharmacy Education (ACPE) or approved by the New Jersey State Board of Pharmacy. The training curriculum must consist of a minimum of 20 contact hours of didactic instruction and practical clinical simulation, covering:

• Basic immunology and the pathology of vaccine-preventable diseases
• CDC Advisory Committee on Immunization Practices (ACIP) vaccine schedules
• Intramuscular (IM), subcutaneous (SubQ), and intradermal injection techniques
• Vaccine storage, cold-chain maintenance, and inventory handling
• Patient screening, contraindications, and informed consent procedures
• Recognition, acute triage, and pharmacological management of severe allergic reactions and anaphylaxis

2. Basic Life Support (BLS) Certification

The pharmacist must maintain active, continuous certification in Basic Life Support (BLS) for Healthcare Providers (or Cardiopulmonary Resuscitation [CPR]) issued by the American Heart Association (AHA), the American Red Cross, or an equivalent Board-approved certifying entity. Crucially, the BLS course must include an in-person, hands-on practical skills evaluation; purely online or non-interactive CPR certifications do not meet Board standards.

3. Continuing Education (CE) Requirement

During each biennial license renewal cycle, an immunizing pharmacist must complete a minimum of two (2) credits of Board-approved continuing education directly related to immunization practice and vaccine therapy. These two CE credits count toward the mandatory 30 contact hours required for biennial pharmacist license renewal.

Supervised Administration: Interns & Externs

Under N.J.A.C. 13:39-4.21(c), registered pharmacy interns and pharmacy externs enrolled in an ACPE-accredited Doctor of Pharmacy program may administer vaccines provided that:

1. The intern or extern has successfully completed the prerequisite 20-hour ACPE-approved immunization training program.
2. The intern or extern maintains current hands-on BLS/CPR healthcare provider certification.
3. The administration occurs under the immediate, direct personal supervision of a certified, immunization-credentialed licensed pharmacist who is physically present in the immediate clinical area.

[!IMPORTANT] MPJE Memory Anchor: 20 hours initial certificate course + hands-on BLS certification + 2 hours immunization CE per renewal period. Registered interns may immunize ONLY if certified AND under direct in-person pharmacist supervision.

---

Modes of Authority: Prescription vs. Physician Standing Order

New Jersey authorizes pharmacists to administer vaccines via two distinct legal pathways:

Mandatory Components of a Standing Order Protocol

When operating under a standing order, the written document must explicitly delineate:

• The identities, license numbers, and practice locations of the authorizing physician and participating pharmacist(s)
• Authorized vaccine types, strengths, and approved anatomical routes of administration
• Clinical inclusion and exclusion criteria, including detailed contraindication screening
• Required patient observation periods following injection
• Immediate medical response protocols and pre-printed algorithms for adverse reactions
• Documentation, notification, and emergency dispatch procedures

---

Patient Age Thresholds & Authorized Vaccine Types

[!WARNING] This framework changed recently — verify the age you memorized. P.L. 2025, c.17 (Assembly Bill A1899, approved February 3, 2025) amended N.J.S.A. 45:14-63 and rewrote the age rules. It (a) lowered the influenza and COVID-19 floor from seven years to five years, (b) extended that authority to pharmacy technicians alongside pharmacists, interns, and externs, and (c) repealed the prior clause that barred administration to a patient under 10 years of age except pursuant to a prescription from an authorized prescriber. The Board of Pharmacy and the Board of Medical Examiners specially adopted conforming amendments to N.J.A.C. 13:39-4.21, 13:39-4.21A, and 13:35-6.26, effective February 12, 2026. Study material written before 2025 will still say "seven," and it is wrong.

The statute now works on two tiers, and the exam tests which tier a given product falls into:

                          N.J.S.A. 45:14-63 — Two Tiers
                                          │
         ┌────────────────────────────────┴────────────────────────────────┐
         ▼                                                                 ▼
  Paragraph (a)(2): Flu + COVID-19                        Paragraph (a)(1): Everything Else
 • Age 5 and older                                        • Drugs and other vaccines:
 • Pharmacist, intern, extern,                              age 18 and older
   OR pharmacy technician                                 • Under the joint BOP/BME rules
 • Under 18: permission of the                            • Younger patients: refer to the
   parent or legal guardian                                 pediatric medical home or obtain
 • No prescription needed at any                            a patient-specific prescription
   age (the under-10 rule is gone)                          from an authorized prescriber

1. Influenza and COVID-19 Vaccines — Age 5 and Older

Under N.J.S.A. 45:14-63(a)(2), an appropriately educated and qualified pharmacist, pharmacy intern, pharmacy extern, or pharmacy technician may administer an influenza vaccine, a COVID-19 vaccine, or both, to a patient who is five years of age or older. Note what the amendment did not do: it did not create a separate lower tier for infants, and it did not carry a training-based exception below age five. Five is the floor.

2. The Under-18 Permission Rule

The same paragraph provides that for a patient who is under 18 years of age, a pharmacist, intern, extern, or technician shall not administer a vaccine except with the permission of the patient's parent or legal guardian. This applies to every vaccine, not only influenza and COVID-19, and it is a permission requirement rather than a prescription requirement — obtaining the parent's authorization is what unlocks the administration. N.J.A.C. 13:39-4.21A carries the operational requirements that attach when influenza or COVID-19 vaccine is administered to a patient under 18.

3. Other Drugs and Vaccines — Age 18 and Older

Under N.J.S.A. 45:14-63(a)(1), administration of drugs and of vaccines other than influenza and COVID-19 runs to patients 18 years of age or older, pursuant to the rules jointly promulgated by the Board of Pharmacy and the State Board of Medical Examiners, and pursuant to one of the authorized bases: a patient-specific prescription, a prescriber's standing order for the vaccine and related emergency medications, or an immunization program (including a program sponsored by a governmental agency) that is not patient-specific. A pediatric patient who needs Tdap, HPV, or MMR is therefore referred to the medical home or presents with a prescription from an authorized prescriber.

4. Technicians, Interns, and Externs Administering Immunizations

N.J.S.A. 45:14-63(a)(3) allows an appropriately educated and qualified pharmacy intern, extern, or technician to administer immunizations by injection or other delivery method, but only while acting under the direct supervision of a licensed pharmacist who is pre-approved by the Board of Pharmacy to administer vaccines and related emergency medications and who complies with the jointly promulgated BOP/BME rules. Two conditions therefore stack: the person giving the injection must be qualified, and a specifically pre-approved pharmacist must be directly supervising. A technician cannot vaccinate in a pharmacy whose only on-duty pharmacist lacks immunization pre-approval.

---

Mandatory Emergency Countermeasures & Anaphylaxis Protocols

Under N.J.A.C. 13:39-4.21(e), patient safety mandates that any pharmacy practice site where vaccines are administered must be physically equipped to manage immediate life-threatening hypersensitivity reactions.

1. Mandatory Emergency Medications On Hand

The administering pharmacist must maintain an active standing order for emergency anaphylaxis management and have immediately accessible the following unexpired medications:

• Epinephrine: Pre-drawn epinephrine syringes or epinephrine auto-injectors (adult formulation 0.3 mg and pediatric formulation 0.15 mg, or equivalent 1:1,000 [1 mg/mL] injectable solution).
• Diphenhydramine: Oral and/or injectable diphenhydramine formulations.

2. Emergency Management Protocol

In the event of an acute anaphylactic reaction (manifested by airway constriction, stridor, bronchospasm, facial angioedema, generalized urticaria, or profound hypotension), the pharmacist must:

1. Immediately position the patient supine (elevating the lower extremities, unless respiratory distress dictates an upright posture).
2. Administer intramuscular epinephrine into the anterolateral aspect of the mid-thigh without hesitation.
3. Call 911 (Emergency Medical Services) immediately to initiate emergency medical transport.
4. Administer secondary pharmacotherapy (e.g., diphenhydramine) only after epinephrine has been deployed and the airway is secured.
5. Repeat the intramuscular epinephrine injection every 5 to 15 minutes if symptoms persist or progress prior to EMS arrival.
6. Continuously monitor vital signs and maintain airway patency until emergency paramedics assume patient care.

[!WARNING] Critical Exam Pitfall: A pharmacy CANNOT administer vaccines if its emergency epinephrine or diphenhydramine is expired, missing, or locked in a remote institutional storage vault. Emergency supplies must be present at the immediate administration site.

---

Reporting, Registry Submission & Recordkeeping Mandates

Accountability and public health disease surveillance require multi-channel documentation following every immunization:

                               Vaccine Administration
                                          │
         ┌────────────────────────────────┼────────────────────────────────┐
         ▼                                ▼                                ▼
  Federal VIS Delivery            NJIIS Registry Filing           Physician Notification
 • CDC VIS handed to patient     • Report to NJ state registry   • Transmit record to PCP
 • Prior to administration       • Within 20 days (or 72 hrs)    • Within 48 to 72 hours
 • Document edition date         • Mandatory electronic entry    • Document if no PCP

1. Vaccine Information Statements (VIS)

Prior to administering each dose of any vaccine covered under the National Childhood Vaccine Injury Act (42 U.S.C. § 300aa-26), the pharmacist must hand the patient (or parent/legal guardian) the most current federal Vaccine Information Statement (VIS) published by the CDC. The pharmacist must allow adequate time for the recipient to read the document and answer all questions. The pharmacy record must document the specific publication date of the VIS provided and the exact date it was delivered to the patient.

2. Reporting to the NJ Immunization Information System (NJIIS)

Pharmacists must report every administered vaccine to the New Jersey Immunization Information System (NJIIS). Under New Jersey administrative rules, vaccination data must be transmitted to the registry within 20 days of administration (or within 72 hours where electronic health record integration or specialized public health orders mandate accelerated reporting). This centralized reporting prevents duplicate dosing and enables statewide immunization tracking.

3. Primary Care Physician Notification

Under N.J.A.C. 13:39-4.21(f), the pharmacist must notify the patient's primary care physician (PCP), if one is identified by the patient, within 48 to 72 hours of vaccine administration. If the patient indicates that they do not have a primary care physician, the pharmacist must document this fact in the pharmacy record and provide the patient with written documentation of the immunization to retain for their personal medical history.

4. Mandatory Record Retention: 5 Years

All documentation relating to immunization administration—including patient screening questionnaires, signed informed consent forms, vaccine lot numbers, expiration dates, manufacturers, anatomical injection sites, administering clinician names, and VIS edition dates—must be maintained by the pharmacy for at least five (5) years pursuant to N.J.A.C. 13:39-7.6.

---

Practical Legal Scenario: Pediatric Walk-in Immunization

Scenario: A mother walks into a community retail pharmacy in Edison, New Jersey, requesting an annual influenza vaccination and a Tdap booster for her 8-year-old son. The pharmacy operates under a standing order protocol executed with a local physician. The staff pharmacist completed an ACPE 20-hour immunization course three years ago and has completed 2 hours of vaccine-related CE each renewal cycle, but the pharmacist's AHA BLS healthcare provider card expired two months ago.

Legal Analysis:

1. Age Assessment: The child is 8 years old. Under New Jersey law, pharmacists operating under a standing order may administer both influenza and CDC-recommended vaccines (including Tdap) to patients ages 7 and older with written parental consent.
2. Parental Consent: The mother must sign an informed consent form and complete a screening questionnaire.
3. Credentialing Deficiency: The pharmacist CANNOT legally administer either vaccine. Even though the pharmacist has the 20-hour certificate and required CE credits, active BLS/CPR certification is an absolute prerequisite. Practicing with an expired BLS card violates N.J.A.C. 13:39-4.21(a).
4. Correct Course of Action: The pharmacist must refuse to administer the vaccines until BLS credentials are fully reinstated or have a credentialed, currently certified colleague administer the doses.